News
Experts call for long-term immunity tracking studies
Vaccine experts are pondering just how long vaccines will be able to provide immunity in a world where some diseases are all but eliminated and natural exposure to many common viruses has ended. Read more...
Researchers explore brain cancer vaccine
Researchers are touting the early results from a study of a new brain cancer vaccine that combines protein antigens extracted from a patient's tumor and matches them with white cells also drawn from Read more...
VaxGen sells anthrax vaccine to its old rival
Reduced to a skeleton crew and a bleak outlook, South San Francisco-based VaxGen sold its experimental anthrax vaccine to its former chief rival, Emergent BioSolutions, for $2 million down and up to Read more...
SPOTLIGHT: Covance wins CRO award
Covance, the inaugural sponsor of FierceVaccines, was recognized as the Best CRO at the 2008 World Vaccine Congress. The award recognizes for providing services that support vaccine development. Read more...
ALSO NOTED: Vaccine benefits studied; Menveo wins head-to-head study;and much more...
Vaccine Market Harvard economist Dr. David E. Bloom has studied the economic impact of an effective national program for vaccinations, outlining how better health improves a person's wealth. Read more...
FDA orders Merck to fix vaccine plant problems
The FDA has given Merck 15 days to decide how to fix Read more...
Discovery offers shortcut to custom flu vaccines
A team of researchers at Emory University and the Oklahoma Medical Research Foundation has found a way to radically upend the way new vaccines are developed to fight a pandemic. Just days after a Read more...
Many infants don't get vaccinations on time
A large group of American parents are having a tough time keeping up with their kids' vaccination schedules. More than a quarter of all children are under-vaccinated, with missed doses accounting Read more...
SPOTLIGHT: Researchers probe attitudes to HPV vaccine
Researchers have found that the younger a girl is, the less likely it is that her mother is prepared to arrange a vaccination against HPV. But the researchers note that the girls would benefit most Read more...
ALSO NOTED: Parents opting out of cervical cancer vaccination; UT professor gets grants for Ebola vaccine research; and much mo
Vaccine Market Roughly three out of every 10 parents in the UK either failed to sign a consent form for the new cervical cancer vaccine or sent in a refusal letter in its place. Read more...
AIDS vaccine researchers years away from success
Following a series of major setbacks trying to develop a vaccine for AIDS, The Independent surveyed the top scientists in the field and discovered a deep layer of pessimism. Only two of the 35 top Read more...
GSK confident it can prevail in vaccine battle
GSK's battle to win over the $2 billion market for cervical cancer vaccines has experienced a few big setbacks. French health officials are now recommending against paying for Cervarix and the FDA Read more...
Genocea wins award for in vitro immune system
Genocea Biosciences has been recognized as the best vaccine startup company at a meeting of the World Vaccine Congress in Washington D.C. Genocea boasts the ability to create the human immune system Read more...
Argos gains funds to tackle proof of concept trial
Argos Therapeutics says that its newly announced $35.2 million Series C will fuel its development through 2009. At that point, says Argos CEO John Bonfiglio, the developer should have proof of Read more...
SPOTLIGHT: Acambis contract offers long-term funding
The announcement that Acambis has won a $425 million, 10-year contract to supply the U.S. government with its smallpox vaccine, along with a new share placement, will provide the company with enough Read more...
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight